A Study to Investigate the Pharmacokinetics and Pharmacodynamics of RO7234292 (RG6042) in CSF and Plasma, and Safety and Tolerability Following Intrathecal Administration in Patients With Huntington's Disease
Clinical trial NCT04000594 · COMPLETED
Trial details
- NCT number
- NCT04000594
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-02
- Primary completion
- 2022-01-18
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.